Physician profile
Michelle Hamilton
NPI 1669134177
$323.72
in general payments reported to CMS, 2019-2025
13 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $111 · 2023: $37.86 · 2024: $13.93 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199 · Entertainment: $13.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.85 |
| Entertainment | $13.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $53.29 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $33.46 | 2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $32.36 | 2022 | |
| Abbvie INC. | $31.16 | 2024-2025 | |
| Novo Nordisk INC | $26.24 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.08 | 2022 | |
| Seqirus USA INC | $23.32 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Otsuka America Pharmaceutical, INC. | $22.56 | 2025 | Rexulti |
| Genentech USA, INC. | $18.75 | 2025 | Xolair |
| Pfizer INC. | $15.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.54 | 2023 | Seglentis |
| Dexcom, INC. | $13.88 | 2025 | Dexcom G6 Transmitter |
| Optos, INC. | $13.62 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.